| The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis AJ Wigg, IC Roberts-Thomson, RB Dymock, PJ McCarthy, RH Grose, ... Gut 48 (2), 206-211, 2001 | 1174 | 2001 |
| The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis AJ Wigg, IC Roberts-Thomson, RB Dymock, PJ McCarthy, RH Grose, ... Gut 48 (2), 206-211, 2001 | 1162 | 2001 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 160 | 2022 |
| Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial J Thompson, N Jones, A Al‐Khafaji, S Malik, D Reich, S Munoz, ... Liver Transplantation 24 (3), 380-393, 2018 | 135 | 2018 |
| Efficacy of a chronic disease management model for patients with chronic liver failure AJ Wigg, R McCormick, R Wundke, RJ Woodman Clinical Gastroenterology and Hepatology 11 (7), 850-858. e4, 2013 | 135 | 2013 |
| Percutaneous thermal ablation for primary hepatocellular carcinoma: a systematic review and meta‐analysis MA Chinnaratha, MA Chuang, RJL Fraser, RJ Woodman, AJ Wigg Journal of Gastroenterology and Hepatology 31 (2), 294-301, 2016 | 115 | 2016 |
| NGM 282 for treatment of patients with primary biliary cholangitis: a multicenter, randomized, double‐blind, placebo‐controlled trial MJ Mayo, AJ Wigg, BA Leggett, H Arnold, AJ Thompson, M Weltman, ... Hepatology communications 2 (9), 1037-1050, 2018 | 114 | 2018 |
| Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12‐year period with more than 100 patients AJ Wigg, BK Gunson, DJ Mutimer Liver transplantation 11 (1), 27-34, 2005 | 98 | 2005 |
| Radiotherapy for hepatocellular carcinoma: systematic review of radiobiology and modeling projections indicate reconsideration of its use AJ Wigg, K Palumbo, DR Wigg Journal of gastroenterology and hepatology 25 (4), 664-671, 2010 | 68 | 2010 |
| Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years AN Koshy, PJ Gow, HC Han, AW Teh, R Jones, A Testro, HS Lim, ... European Heart Journal-Quality of Care and Clinical Outcomes 6 (4), 243-253, 2020 | 57 | 2020 |
| Increasing incidence of nonalcoholic steatohepatitis as an indication for liver transplantation in Australia and New Zealand L Calzadilla‐Bertot, GP Jeffrey, B Jacques, G McCaughan, M Crawford, ... Liver transplantation 25 (1), 25-34, 2019 | 50 | 2019 |
| Efficacy and safety of mycophenolate mofetil in patients with autoimmune hepatitis and suboptimal outcomes after standard therapy SK Roberts, R Lim, S Strasser, A Nicoll, A Gazzola, J Mitchell, W Siow, ... Clinical Gastroenterology and Hepatology 16 (2), 268-277, 2018 | 49 | 2018 |
| Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: a multicenter, exploratory analysis MF Silva, G Sapisochin, SI Strasser, S Hewa-Geeganage, J Chen, ... European Journal of Surgical Oncology (EJSO) 39 (4), 386-395, 2013 | 42 | 2013 |
| High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice MA Chinnaratha, D Sathananthan, P Pateria, E Tse, G MacQuillan, ... European Journal of Gastroenterology & Hepatology 27 (3), 349-354, 2015 | 37 | 2015 |
| Additive impact of pre‐liver transplant metabolic factors on survival post‐liver transplant LA Adams, O Arauz, PW Angus, M Sinclair, GA MacDonald, ... Journal of Gastroenterology and Hepatology 31 (5), 1016-1024, 2016 | 34 | 2016 |
| Optimisation of hepatocellular carcinoma surveillance in patients with viral hepatitis: a quality improvement study NA Kennedy, A Rodgers, R Altus, R McCormick, R Wundke, AJ Wigg Internal Medicine Journal 43 (7), 772-777, 2013 | 33 | 2013 |
| Hepatobiliary and Pancreatic: Early palliative care referral in patients with end‐stage liver disease is associated with reduced resource utilization A Barnes, RJ Woodman, P Kleinig, M Briffa, T To, AJ Wigg Journal of Gastroenterology and Hepatology 35 (5), 840-845, 2020 | 32* | 2020 |
| Liver support systems: promise and reality AJ Wigg, RT Padbury Journal of gastroenterology and hepatology 20 (12), 1807-1816, 2005 | 31 | 2005 |
| Real‐world outcomes of unrestricted direct‐acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience J Haridy, A Wigg, K Muller, J Ramachandran, E Tilley, V Waddell, ... Journal of viral hepatitis 25 (11), 1287-1297, 2018 | 30 | 2018 |
| NGM282, a novel variant of FGF-19, demonstrates biologic activity in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid: results of a phase … MJ Mayo, AJ Wigg, SK Roberts, H Arnold, TI Hassanein, BA Leggett, ... Hepatology 62, 263A-264A, 2015 | 29 | 2015 |
